CoChat
Sign Up
Cited by 97Transplantation: Methods and OutcomesOrgan Transplantation Techniques and OutcomesOrgan Donation and Transplantation

Long-term outcome after pulmonary retransplantation

Open access
Strueber, Martin, Fischer, Stefan, Gottlieb, Jens, Simon, Andre R., Goerler, Heidi, Gohrbandt, Bernhard, Welte, Tobias, Haverich, Axel·2006·The Journal of Thoracic and Cardiovascular Surgery
DOI 10.1016/j.jtcvs.2005.12.059
Open this paper in CoChat — free accountOpen PDF

Abstract

Objective Bronchiolitis obliterans syndrome has become the most limiting factor for long-term outcome after lung transplantation. Redo lung transplantation was performed for end-stage bronchiolitis obliterans syndrome. Long-term outcome was compared with that after primary lung transplantation as well as with other indications for retransplantation. Methods Of 614 lung transplantation procedures performed at our institution, 54 (8.5%) were redo transplants. These were stratified into different groups according to the indication for redo transplantation, including chronic graft failure/bronchiolitis obliterans syndrome, acute graft failure, and posttransplantation airway complications. Long-term survival was compared with that of the primary lung transplantation cohort, thereby respecting the need for pretransplant mechanical ventilatory support in a subanalysis. In addition, recurrence of bronchiolitis obliterans syndrome after redo lung transplantation was compared with the occurrence of bronchiolitis obliterans after primary transplantation. Results A 1-year survival of 50% was achieved after redo lung transplantation for acute graft failure and airway complications as well as after primary lung transplantation in patients with pretransplant ventilatory support. Retransplantation for bronchiolitis obliterans syndrome revealed superior 1- (78%) and 5-year (62%) survivals, which were not different from those of first-time lung transplant recipients. In addition, we found a similar incidence of bronchiolitis syndrome after retransplantation for BOS compared with its occurrence after primary lung transplantation. Conclusion Redo lung transplantation for end-stage bronchiolitis obliterans syndrome leads to acceptable long-term outcome in selected patients. Future analyses of redo lung transplantation data should generally stratify bronchiolitis obliterans syndrome from other indications with higher mortality.

Integrity signals

Registry

Crossref · 10.1016/j.jtcvs.2005.12.059

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ReTx accounted for only 3.9% of our total volume, which was lower than the 4-16% reported in previous single-center studies and the 4-6% reported in the ISHLT registry between 2005 and 2017.

    “Despite performing over 1000 lung transplants during the 18-year study period, ReTx accounted for only 3.9% of our total volume, which was lower than the 4–16% reported in previous single-center studies across the U.S., North America, and Europe,3, 6, 7, 8, 9 and the 4–6% reported in the ISHLT registry between 2005 and 2017.5”

    From Lung retransplantation during the Lung Allocation Score era: Outcomes from a large single center (2026) · cites this paper as [7]

  • Younger age, lower acute graft dysfunction, and longer interval between primary and ReTx have all been previously linked to ReTx survival differences.

    “These factors had all been previously linked to ReTx survival differences.3, 4, 5, 6, 7, 8, 10, 11, 12, 13”

    From Lung retransplantation during the Lung Allocation Score era: Outcomes from a large single center (2026) · cites this paper as [7]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Strueber, M., Fischer, S., Gottlieb, J., Simon, A. R., Goerler, H., Gohrbandt, B., Welte, T., & Haverich, A.
Affiliations
Medizinische Hochschule Hannover (DE)
Corresponding author
Strueber, Martin
ORCID
Venue
The Journal of Thoracic and Cardiovascular Surgery
Publisher
Elsevier BV
Published
2006-08
Volume
132
Issue
2
Pages
407-412
ISSN
0022-5223 (ISSN-L)
DOI
10.1016/j.jtcvs.2005.12.059
OpenAlex
W2042577913
Cited by
97
References
15
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 11 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 4
FWCI
6.46
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Thoracic and Cardiovascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
Keywords
bronchiolitis obliterans syndrome, chronic graft failure, acute graft failure, long-term survival
MeSH terms
Adolescent, Adult, Aged, Bronchiolitis Obliterans, Cause of Death, Female, Humans, Male, Middle Aged, Quality of Life, Reoperation, Respiration, Artificial, Survival Analysis, Lung Transplantation, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review